Publications by authors named "Aaron Hansen"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

45

Total Likes

20

Extended Reach

30,016

Social Features

13
I
Investigating Early Kinetics in Plasma ctDNA and Peripheral T Cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Cancer.
Enrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce, Stephanie Pedersen, Marian Tang, Aaron R Hansen

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INDUCE-3: A randomized Phase II/III study of first-line feladilimab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Danny Rischin, Aaron R Hansen, Ezra E W Cohen, Makoto Tahara, Kevin J Harrington

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARTSCAN: Time to Rethink De-escalation in LA-HNSCC.
Laura Tam, Aaron R Hansen

Int J Radiat Oncol Biol Phys· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumab.
Shirin Soleimani, Xuan Li, Ben X Wang, Stephanie Pedersen, Jeffrey P Bruce, Aaron R Hansen

Cell Rep· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Chemoradiotherapy for Oral Cavity SCC With Minor and Major Extranodal Extension.
Mirko Manojlovic-Kolarski, Susie Su, Ilian Weinreb, Robert Calvisi, Bayardo Perez-Ordonez, Aaron Hansen

JAMA Otolaryngol Head Neck Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors.
Michele Maio, Victor Moreno, Juan Martin-Liberal, Frans Opdam, Aaron Hansen

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative Study.
John R de Almeida, Jie Su, Abdullah AlShenaiber, Hesameddin Noroozi, Matthias Buttner, Aaron Hansen

JAMA Otolaryngol Head Neck Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Nations Australians and head and neck cancer: health professionals' priorities for improving the pathway of care.
Stephanie Ng, Elizabeth C Ward, Gail Garvey, Tamara Butler, Joanne Tesiram, Aaron Hansen

Support Care Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors.
Benedito A Carneiro, Robert M Jotte, Nashat Y Gabrail, Kristopher Wentzel, Funan Huang, Aaron R Hansen

Cancer Res Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From many voices, one question: Community co-design of a population-based qualitative cancer research study.
Susannah K Ayre, Elizabeth A Johnston, Xanthia E Bourdaniotis, Leah Zajdlewicz, Vanessa L Beesley, Aaron Hansen

PLoS One· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results.
David M O'Malley, Giovani M Bariani, Philippe A Cassier, Aurelien Marabelle, Aaron R Hansen

Gynecol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer.
Eric Winquist, Sebastien J Hotte, Kim Chi, Srikala Sridhar, Susan Ellard, Aaron Hansen

Clin Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.
Emiliano Calvo, Bernard Doger, Joan Carles, Avivit Peer, David Sarid, Aaron R Hansen

Oncologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial clinical experience with [Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial.
Aaron R Hansen, Stephan Probst, Jean-Mathieu Beauregard, Benjamin L Viglianti, Jeff M Michalski

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma.
Aaron R Hansen, Carlos A Gomez-Roca, Debbie G J Robbrecht, Loic Verlingue, Antoine Italiano

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable.
Christina Yap, Olalekan Lee Aiyegbusi, Emily Alger, Ethan Basch, Jill Bell, Aaron R Hansen

EClinicalMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer.
Alberto Hernando-Calvo, Ming Han, Olubukola Ayodele, Ben X Wang, Jeffrey P Bruce, Aaron R Hansen

Clin Colorectal Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors.
Maxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, Drew Rasco, Yan Xing

Invest New Drugs· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial.
John R de Almeida, Rosemary Martino, Ali Hosni, David P Goldstein, Scott V Bratman, Aaron R Hansen

JAMA Otolaryngol Head Neck Surg· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.
Marc Oliva, Alya Heirali, Geoffrey Watson, Ashley M Rooney, Kyla Cochrane, Aaron R Hansen

Br J Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H Miller, Aaron R Hansen

Invest New Drugs· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Emanuel Bührer, David D'Haese, Gedske Daugaard, Ronald de Wit, Costantine Albany, Aaron R Hansen

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r future.
Harriet Lampe, Laura Tam, Aaron R Hansen

Front Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience.
Esmail Al-Ezzi, Abhenil Mittal, Zachary W Veitch, Amer Zahralliyali, Nely Mercy Diaz Mejia, Aaron R Hansen

J Kidney Cancer VHL· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis